Children and Families Services Programs
Schedules
TAFS: 075-1536 2022/2026 - Children and Families Services Programs
| Previously Approved (Iteration 1) | OMB Action (Iteration 2) | |||||
|---|---|---|---|---|---|---|
| Line # | Split | Description | Amount | Footnotes | Amount | Footnotes |
| 1151 | BA: Disc: Appropriations:Antic nonexpend trans net | $39,685,100.00 | $40,035,100.00 | |||
| 1920 | Total budgetary resources avail (disc. and mand.) | $39,685,100.00 | $40,035,100.00 | |||
| 6004 | Category A -- 4th quarter | Line added | $350,000.00 | |||
| 6011 | Head Start Category B | $20,000,000.00 | $20,000,000.00 | |||
| 6013 | Child Abuse/Child Welfare Programs | $10,673,100.00 | $10,673,100.00 | |||
| 6016 | Social Services R&D | $9,012,000.00 | $9,012,000.00 | |||
| 6190 | Total budgetary resources available | $39,685,100.00 | See footnotes below | $40,035,100.00 | ||
| Footnotes for line 6190 (Previous): | A1: Pursuant to 31 USC 1553(b), not to exceed 1 percent of the total appropriation for this account is apportioned for the purpose of paying legitimate obligations related to cancelled appropriations. | |||||
Footnotes
Footnotes provide further information about, or establish further legal requirements related to the use of, the funds in a given line or set of lines in an apportionment. If footnotes appear on lines 1920 or 6190, they apply to all the lines in the 1xxx and 6xxx sections, respectively. The following are all the footnotes associated with this file.
No footnotes available.
The following are all of the footnotes associated with the previous iteration of this file. Note that previous iterations of accounts in this file may come from multiple previous files.
| Number | Text |
|---|---|
| A1 | Pursuant to 31 USC 1553(b), not to exceed 1 percent of the total appropriation for this account is apportioned for the purpose of paying legitimate obligations related to cancelled appropriations. |
Notes about this page
- † Links to public laws are automatically generated and are not guaranteed to be accurate.